Stock Analysts’ updated eps estimates for Tuesday, August 22nd:
SLM Solutions Group AG (ETR:AM3D) was given a €27.50 ($32.35) price target by analysts at equinet AG. The firm currently has a sell rating on the stock.
Aradigm Corporation (NASDAQ:ARDM) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $1.50 price target on the stock. According to Zacks, “Aradigm Corp. is a leading developer of advanced pulmonary drug delivery systems for the treatment of systemic conditions as well as lung diseases. Their hand-held AERx platform is being designed for the rapid and reproducible delivery of a wide range of pharmaceutical drugs and biotech compounds via the lung. “
Aspen Aerogels (NYSE:ASPN) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Aspen Aerogels, Inc. is an energy technology company that designs, develops and manufactures aerogel insulation used primarily in large-scale energy infrastructure facilities. The Company offers insulation for high temperature steam pipes, vessels, and equipment. Aspen serves petrochemical, refinery, industrial, and power generation sectors. It manufactures Cryogel (R), Pyrogel (R) and Spaceloft (R) products. Aspen Aerogels, Inc. is headquartered in Northborough, Massachusetts. “
Amerisur Resources (NASDAQ:ASUXF) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Amerisur Resources PLC is an oil and gas exploration and production company. Its primarily portfolio of assets consists in Colombia and Paraguay. Amerisur Resources PLC is headquartered in Wales, Great Britain. “
Athersys (NASDAQ:ATHX) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Athersys is a biopharmaceutical company engaged in the discovery and development of therapeutic product candidates designed to extend and enhance the quality of human life. The company’s lead product candidate, ATHX-105, is an oral, selective 5HT2c receptor agonist in Phase I clinical trials for the treatment of obesity. The company is also developing other orally active pharmaceutical product candidates for the treatment of metabolic and central nervous system disorders, utilizing proprietary technologies, including Random Activation of Gene Expression (RAGE). Athersys is developing MultiStem(r), its patented, adult-derived “off the shelf” stem cell product platform, for multiple disease indications, including damage caused by myocardial infarction, bone marrow transplantation/oncology support, ischemic stroke and other indications. “
Banco De Chile (NYSE:BCH) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $98.00 target price on the stock. According to Zacks, “Banco De Chile is principally engaged in commercial banking in Chile, providing general banking services to a diverse customer base that includes large corporations, small and mid-sized businesses and individuals. “
Bertrandt AG (ETR:BDT) was given a €58.00 ($68.24) target price by analysts at Hauck & Aufhaeuser. The firm currently has a sell rating on the stock.
Biohaven Pharmaceutical Holding Co (NASDAQ:BHVN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Biohaven Pharmaceutical Holding Company Ltd. is a biopharmaceutical company. It focuses on the identification and development of orphan neurologic indications and other neurological pathways. The company’s pipeline includes BHV-0223, which is a formulation of a glutamate-modulating agent; BHV-4157, which is a new chemical entity that modulates glutamate and BHV-5000, which is an in-licensed investigational agent of the Company targeting N-Methyl-D-Aspartate receptor antagonism which are in clinical trial stage. Biohaven Pharmaceutical Holding Company Ltd. is based in NEW HAVEN, United States. “
BHP Billiton plc (LON:BLT) had its target price raised by Morgan Stanley from GBX 1,050 ($13.63) to GBX 1,410 ($18.30). They currently have an overweight rating on the stock.
Bouygues (NASDAQ:BOUYY) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “Bouygues SA is a diversified industrial group. The company’s business sectors of activity consists of Construction includes building & civil works and energies & services, Immobilier includes property development and Colas, Telecoms, with Bouygues Telecom and Media, with TF1. Bouygues SA is based in Paris, France. “
Grupo Financiero Santander Mexico S.A. B. de C.V. (NYSE:BSMX) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. They currently have $12.00 target price on the stock. According to Zacks, “Grupo Financiero Santander Mexico SAB de CV is engaged in providing various banking services primarily in Mexico. It provides multiple banking services, securities brokerage, financial advice services, as well as other related investment activities. The company also offers pension and investment funds; cards and other structured products; and treasury management, merchant, trust, life insurance, online collection, tax payment, payroll, and cash management services. Grupo Financiero Santander Mexico SAB de CV is based in Mexico City, Mexico. “
Sierra Bancorp (NASDAQ:BSRR) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $28.00 target price on the stock. According to Zacks, “Sierra Bancorp is the bank holding company for the Bank of the Sierra. The Bank of the Sierra is the largest independent bank headquartered in the South Valley, and operates branch offices as well as real estate centers, agricultural credit centers and a bank card center. “
BT Group PLC (NYSE:BT) was downgraded by analysts at Zacks Investment Research from a buy rating to a hold rating. According to Zacks, “BT is one of the world’s leading providers of communications services and solutions, serving customers in more than 170 countries. Its principal activities include the provision of networked IT services globally; local, national and international telecommunications services to its customers for use at home, at work and on the move; broadband and internet products and services and converged fixed/mobile products and services. BT consists principally of four lines of business: BT Global Services, BT Retail, BT Wholesale and Openreach. British Telecommunications plc (BT) is a wholly-owned subsidiary of BT Group plc and encompasses virtually all businesses and assets of the BT Group. BT Group plc is listed on stock exchanges in London and New York. “
Broadwind Energy (NASDAQ:BWEN) was upgraded by analysts at Zacks Investment Research from a sell rating to a hold rating. According to Zacks, “Broadwind Energy is a precision manufacturer of structures, equipment & components for clean tech and other specialized applications. Their most significant presence is within the U.S. wind energy industry, although they have diversified into other industrial markets in order to improve their capacity utilization and reduce their exposure to uncertainty related to favorable governmental policies currently supporting the U.S. wind energy industry. Within the U.S. wind energy industry, they provide products primarily to wind turbine manufacturers. Outside of the wind energy market, they provide precision gearing and specialty weldments to a broad range of industrial customers for oil and gas, mining, steel and other industrial applications. “
CymaBay Therapeutics (NASDAQ:CBAY) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “CymaBay Therapeutics Inc. is a biopharmaceutical company. It is focused on the development and commercialization of proprietary new medicines for important human diseases. The Company’s lead product candidate, arhalofenate, is being developed for the treatment of gout. CymaBay Therapeutics Inc. is based in Newark, California. “
CB Financial Services (NASDAQ:CBFV) was upgraded by analysts at Zacks Investment Research from a hold rating to a buy rating. Zacks Investment Research currently has $32.00 target price on the stock. According to Zacks, “CB Financial Services, Inc. is the bank holding company for Community Bank, a chartered commercial bank. The Bank’s services include personal banking and business banking. It offers checking, loan accounts, individual retirement accounts, wealth management, certificates of deposit, recorder check, business checking accounts, business loans, cash management and re-order check. The Bank offers other services, including merchant services, financial and wealth management, wire transfers, credit card, ATM, and online banking services. It serves business owners, non-profit groups, government agencies, school administrators, and individual personal account holders in Pennsylvania. CB Financial Services, Inc. is based in Carmichaels, Pennsylvania. “
Compugen (NASDAQ:CGEN) was downgraded by analysts at Zacks Investment Research from a hold rating to a sell rating. According to Zacks, “Compugen Ltd. is a pioneer in the fields of computational genomics and proteomics. The company combines the disciplines of mathematics and computer science with molecular biology to improve the understanding of genomics and proteomics, the study of genes and proteins. Compugen’s expertise in these areas is used to develop core technologies and platforms that are the basis for its products and services. These products and services are designed to enable life scientists to significantly enhance their research efforts in drug discovery. “
Cairn Energy PLC (LON:CNE) had its price target lowered by Royal Bank Of Canada from GBX 270 ($3.51) to GBX 230 ($2.99). They currently have an outperform rating on the stock.
Deere & (NYSE:DE) was downgraded by analysts at Credit Suisse Group from a neutral rating to an outperform rating.
Global Medical REIT (NASDAQ:GMRE) was downgraded by analysts at DA Davidson to a hold rating.
Hain Celestial Group (NASDAQ:HAIN) was given a $45.00 target price by analysts at Susquehanna Bancshares Inc. The firm currently has a hold rating on the stock.
Provident Financial plc (LON:PFG) had its under review rating reiterated by analysts at Peel Hunt.
RadNet (NASDAQ:RDNT) was upgraded by analysts at Jefferies Group LLC to a buy rating.
Randgold Resources Limited (LON:RRS) had its price target boosted by HSBC Holdings plc from GBX 6,550 ($85.03) to GBX 7,800 ($101.26). The firm currently has a hold rating on the stock.
Sorrento Therapeutics (NASDAQ:SRNE) was given a $7.00 price target by analysts at Oppenheimer Holdings, Inc.. The firm currently has a buy rating on the stock.
Stabilus SA (ETR:STM) was given a €75.00 ($88.24) price target by analysts at Warburg Research. The firm currently has a neutral rating on the stock.
VTG AG (ETR:VT9) was given a €45.00 ($52.94) target price by analysts at Nord/LB. The firm currently has a neutral rating on the stock.
zooplus AG (ETR:ZO1) was given a €149.00 ($175.29) price target by analysts at Warburg Research. The firm currently has a neutral rating on the stock.
